Has the Rebound Begun for Empire Company Limited?

Empire Company Limited (TSX:EMP.A) looks like a promising rebound play with Michael Medline on board. Here’s what you should do today.

| More on:
grocery store

Empire Company Limited (TSX:EMP.A) soared nearly 10% in a single trading session following an impressive earnings report. Earnings per shares were $0.18, which beat analyst expectations of $0.12.

In previous pieces, I mentioned that Michael Medline was the right man to turn Empire around and that the stock was a terrific long-term contrarian play. I thought the rebound would be at least a few years away, but after a few months at the helm, it appears that Empire is back on the right track a lot sooner than expected.

Turnaround plan: Keep things simple

Although Mr. Medline didn’t have prior grocery experience, he knows the Canadian retail environment very well, and he knows how to make operations run in an efficient manner. Before Mr. Medline jumped on board, Empire was a tangled web of organizational inefficiencies. The grocery business is really difficult to thrive in with low margins and food deflation, so an efficient and simple organizational structure is simply a must if profits are going to be made.

Mr. Medline created a three-year turnaround transformation plan called Project Sunrise earlier in the year. It aimed to reduce costs and organizational complexity. So far, it looks like the plan is starting to take shape, but it’s important to note that the company is “not out of the woods yet,” as Mr. Medline said following the release of the Q4 results.

The management team expects to spend $200 million in the first half of 2018 to reduce long-term costs. Such initiatives that the money will go towards include minor system developments, consulting, and relocation. It’s expected there will be about $500 million worth of annualized cost savings by 2020 with the cost savings in place.

While the general public seems to love the latest earnings beat, the results were still quite weak, and it’s possible that analysts will raise the bar for the results expected in the next quarter. Although Mr. Medline’s changes seem to be affecting the stock price, it’s important that investors take a long-term view because real meaningful changes are going to take time.

Should you buy today?

It’s very encouraging that Mr. Medline’s improvements are working, but it’s important to remember that Project Sunrise is a long-term plan. If you’re looking for a quick turnaround play, then you may be left disappointed as volatility is likely to pick up in the coming months as Amazon.com, Inc. sets its sights on the grocers.

I still think Mr. Medline will turn Empire around, but I’m not a fan of the price anymore because it appears Empire has run ahead of reality. If you’re a patient investor with a long-term horizon, then you may be able to get a better entry point in the coming months as the hype from the latest earnings report fades.

Stay smart. Stay hungry. Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette has no position in any stocks mentioned. David Gardner owns shares of Amazon. The Motley Fool owns shares of Amazon.

More on Investing

Growth from coins
Stocks for Beginners

3 Incredibly Cheap Canadian Growth Stocks to Buy Today

Canadian growth stocks are cheaper than they have been in a long time. Here are three stocks that are incredible…

Read more »

Stock analysts were once excited about construction company Aecon as an investment.

Bull or Bear: Why Analysts Changed Their Tune on Aecon Stock

Analysts had been champing at the bit for the construction company, but the tides have turned.

Read more »

Specialty Brands faces higher raw materials costs.
Dividend Stocks

What’s Next for Premium Brands Stock?

Shares of the specialty food production and distribution company have fallen about 25% since last October.

Read more »

Double exposure of a businessman and stairs - Business Success Concept
Dividend Stocks

2 Interesting Buys in Any Market

Here are two intriguing buys in any market climate that offer defensive appeal as well as growth and income earning…

Read more »

Bank sign on traditional europe building facade
Bank Stocks

Should You Buy Bank Stocks Now?

Canadian bank stocks are getting cheap. Is this the right time to buy?

Read more »

stock data
Stocks for Beginners

2 Reliable Stocks Beginners Can Buy Amid the Market Selloff

As the broader market turmoil continues, new investors can buy these two reliable dividend stocks to get good returns on…

Read more »

Biotech stocks can be good yet risky investments.

Is Bellus Health Stock Still a Buy After 30% Earnings Jump?

The biotech continues to make progress on obtaining FDA approval for its chronic-cough therapy.

Read more »

Dividend Stocks

TFSA Investors: 3 TSX Stocks for Tax-Free Passive Income

These Canadian corporations have strong visibility over future earnings and dividend payouts.

Read more »